Clinical Trial Update: Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating topical ruxolitinib for facial and neck vitiligo in adult Chinese patients refractory to tacrolimus; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Topical ruxolitinib (ruxolitinib)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Vitiligo | Phase 2, Phase 3 | Status: RECRUITING